Literature DB >> 2564135

Adjuvant tamoxifen and second cancers.

T Fornander, L E Rutqvist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2564135     DOI： 10.1016/s0140-6736(89)91641-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

Review 2.  What do we know and what don't we know about tamoxifen in the human uterus.

Authors:  A Friedl; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

3.  The Prescription Pattern of Chinese Herbal Products Containing Ginseng among Tamoxifen-Treated Female Breast Cancer Survivors in Taiwan: A Population-Based Study.

Authors:  Wei-Lung Hsu; Yueh-Ting Tsai; Chien-Tung Wu; Jung-Nien Lai
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-01       Impact factor: 2.629

4.  Who should participate in clinical trials and who not? Can clinical trials be made more efficient and effective?

Authors:  Kathleen I Pritchard
Journal:  Breast Cancer Res       Date:  2008-12-18       Impact factor: 6.466
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.